Click to view your profile
Click to search for condition or expert
Click to open main menu
Large-Cell Lung Carcinoma Latest Advances
Find the Latest Research About Large-Cell Lung Carcinoma
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated : 05/19/2022
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
See more filters
Recurrent Postoperative Lung Cancer with Tumor Shrinkage after Discontinuation of Pembrolizumab-A Case Report.
Condition:
Recurrent Postoperative Lung Cancer
Journal:
Gan to kagaku ryoho. Cancer & chemotherapy
Treatment Used:
Discontinuation of Pembrolizumab
Number of Patients:
1
Published:
January 20, 2022
View publication
Summary:
Recurrent Postoperative Lung Cancer with Tumor Shrinkage after Discontinuation of Pembrolizumab-A Case Report.
Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report.
Condition:
Pulmonary Large Cell Neuroendocrine Carcinoma
Journal:
The Journal of international medical research
Treatment Used:
Albumin-Bound Paclitaxel plus Platinum-Based Chemotherapy with Radiotherapy and Durvalumab
Number of Patients:
1
Published:
November 05, 2021
View publication
Summary:
Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report.
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
Condition:
Non-Small Cell Lung Cancer (NSCLC)
Journal:
BMC pulmonary medicine
Treatment Used:
Immune Checkpoint Inhibitors (ICIs)
Number of Patients:
175
Published:
October 03, 2021
View publication
Summary:
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Condition:
Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Journal:
Asian Pacific journal of cancer prevention : APJCP
Treatment Used:
Immunotherapy
Number of Patients:
37
Published:
February 28, 2021
View publication
Summary:
Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung.
Condition:
Large-Cell Neuroendocrine Lung Carcinoma (aLCNEC)
Journal:
Journal for immunotherapy of cancer
Treatment Used:
Immune Checkpoint Inhibitors (ICI)
Number of Patients:
125
Published:
February 18, 2021
View publication
Summary:
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung.
Large cell neuroendocrine carcinoma of the lungs: case report and literature review.
Condition:
Large cell neuroendocrine carcinoma (LCNEC) of Lungs
Journal:
Annals of palliative medicine
Treatment Used:
Surgery, Radiotherapy, Chemotherapy, and Immunotherapy
Number of Patients:
1
Published:
October 17, 2020
View publication
Summary:
Large cell neuroendocrine carcinoma of the lungs: case report and literature review.
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.
Condition:
Treatment-Refractory Non-Small-Cell Lung Cancer (NSCLC)
Journal:
Journal for immunotherapy of cancer
Treatment Used:
Adoptive Transfer of Zoledronate-Expanded Autologous V?9V?2 T-Cells
Number of Patients:
25
Published:
September 19, 2020
View publication
Summary:
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.
Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
Condition:
Combined Small Cell Lung Cancer
Journal:
Lung cancer (Amsterdam, Netherlands)
Treatment Used:
Radical R0 Surgery
Number of Patients:
181
Published:
June 28, 2020
View publication
Summary:
Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.
Condition:
Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
Journal:
Lung cancer (Amsterdam, Netherlands)
Treatment Used:
SC-002
Number of Patients:
35
Published:
May 22, 2020
View publication
Summary:
SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.
Condition:
Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal:
Advances in therapy
Treatment Used:
Immunotherapy
Number of Patients:
60
Published:
May 22, 2020
View publication
Summary:
Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.
Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease.
Condition:
Lung Cancer combined with Interstitial Lung Disease
Journal:
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Treatment Used:
Surgery
Number of Patients:
23
Published:
May 21, 2020
View publication
Summary:
Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease.
Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC).
Condition:
Large Cell Neuroendocrine Tumors of Lung
Journal:
Lung cancer (Amsterdam, Netherlands)
Treatment Used:
Immune Check-point Inhibitors
Number of Patients:
37
Published:
March 24, 2020
View publication
Summary:
Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC).
Showing 1-12 of 36
Next
Last Updated : 05/19/2022